Cargando…
Older renal cell cancer patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data
BACKGROUND: Venous thromboembolic co-morbidities can have a significant impact on treatment response, treatment options, quality of life, and ultimately, survival from cancer. The extent of venous thromboembolic co-morbidity among older renal cell cancer patients is poorly described in the literatur...
Autores principales: | Connelly-Frost, Alexandra, Shantakumar, Sumitra, Kobayashi, Monica G, Li, Haojie, Li, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648500/ https://www.ncbi.nlm.nih.gov/pubmed/23621951 http://dx.doi.org/10.1186/1471-2407-13-209 |
Ejemplares similares
-
Older soft tissue sarcoma patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data
por: Shantakumar, Sumitra, et al.
Publicado: (2015) -
Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER‐Medicare analysis
por: Ades, Steven, et al.
Publicado: (2022) -
Recurrence rate of venous thromboembolic events in granulomatosis with polyangiitis
por: Nevares, Alana, et al.
Publicado: (2022) -
Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data
por: Wieder, Robert, et al.
Publicado: (2023) -
Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods
por: Aly, Abdalla, et al.
Publicado: (2015)